Fig 1.
Main comorbidities of COVID-19 patients admitted in IMU.
Abbreviations: CKD, chronic kidney disease; CNS, central nervous system, CVD, cardiovascular disease; T2D, type 2 diabetes.
Fig 2.
Outcomes among different BMI classes.
Abbreviations: BMI, body mass index; VS, ventilation support. Numbers in bold indicate absolute number of patients.
Table 1.
Baseline characteristics of COVID-19 patients who presented unfavorable outcomes (ventilation support need and death) and those who did not.
Table 2.
Baseline clinical parameters of COVID-19 patients who presented unfavorable outcomes (ventilation support need and death) and those who did not.
Table 3.
Age- and gender-adjusted odds ratios of associations between comorbidities and ventilation support or in-hospital mortality.
Table 4.
Age—and gender-adjusted odds ratios of significant associations between biochemical parameters assessed at day 1 and unfavorable outcomes (ventilation support and death).
Table 5.
Significant age- and gender-adjusted associations of biochemical parameters assessed at day 7 with unfavorable outcomes (VS and death).
Table 6.
Anti-SARS-CoV-2 IgG antibodies levels in patients who presented unfavorable outcomes (VS and death) and in those who did not.